MedTrace Logo

Observational Cohort of COVID-19 Patients in Hubei Province

NCT05615792 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 68000

Last updated 2024-03-07

No results posted yet for this study

Summary

This study intends to use the relevant case data of COVID-19 in Hubei Province, using big data processing and mining methods to evaluate the effects of clinical indicators, drug use and genes on the clinical prognosis of COVID-19 patients, so as to provide a theoretical basis for the treatment of these diseases and reduce the mortality.

Conditions

  • 2019 Novel Coronavirus Disease

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Dao Wen Wang

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2024-03-01
Completion
2024-03-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05615792 on ClinicalTrials.gov